Terumo (OTCMKTS:TRUMY) Shares Gap Up After Better-Than-Expected Earnings

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped up before the market opened on Monday following a better than expected earnings announcement. The stock had previously closed at $14.54, but opened at $16.14. Terumo shares last traded at $16.19, with a volume of 4,271 shares changing hands.

The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.55%. The company had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.84 billion.

Wall Street Analyst Weigh In

Separately, Nomura upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

Terumo Stock Performance

The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59. The company has a market capitalization of $23.88 billion, a price-to-earnings ratio of 22.80 and a beta of 0.68. The firm has a 50-day simple moving average of $14.00 and a two-hundred day simple moving average of $13.56.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.